Drug Search Results

Cotinine

Alternative Names: cotinine
Latest Update: 2024-10-23
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: nAChR Binder

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Inhalant

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: National Institute on Drug Abuse (NIDA)
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Cotinine

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Chronic Pain|Acute Pain

Phase 2: Tobacco Use Disorder

Trial	Phase	Trial Status	Disease	Primary Completion Date
NCT04274673	P4	Unknown status	Chronic Pain\|Acute Pain	2020-05-13
NCT03062709	N/A	Completed	Pneumonia\|Bronchiolitis\|Smoking Cessation\|Bronchopulmonary Dysplasia\|Asthma\|Tobacco Use Disorder	2017-03-30
SCUSF 1201	P2	Withdrawn	Tobacco Use Disorder	2016-06-01

Recent News Events

Date	Type	Title
05/15/2024	PubMed	Relation Between Exposure to Tobacco Smoke Assessed by Serum Cotinine Concentration and Questionnaire Method, and Serum Renalase Concentration-the Importance of the Coexistence of Arterial Hypertension and Other Cardiovascular Diseases.
05/14/2024	PubMed	Association between secondhand smoke exposure and rheumatoid arthritis in US never-smoking adults: a cross-sectional study from NHANES.
05/13/2024	PubMed	UHPLC-MS/MS combined with microdialysis for simultaneous determination of nicotine and neurotransmitter metabolites in the rat hippocampal brain region: application to pharmacokinetic and pharmacodynamic study.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions